Artal Group S.A. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001053906

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedConsumer TiltHigh Turnover how tags are computed

Q3 2023 · 100 positions · Total reported value $2.19B · Top-10 concentration 70.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 33.3% · 1 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2023 13F filing, Artal Group S.A. disclosed 100 equity positions with a combined reported value of $2.19B. The filing implies a focused portfolio: its ten largest positions account for 70.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Consumer Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were CAVA ($980.40M), LXRX ($128.13M), ONC ($72.66M). By sector, the heaviest allocations are Consumer Discretionary 45.7%, Health Care 32.4%.

Versus the prior quarter, Artal Group S.A. opened 1 new positions, trimmed 0 and fully exited 0, a turnover rate of 33.3% of positions.

The largest new positions opened in Q3 2023 were CAVA ($980.40M), LXRX ($128.13M), ONC ($72.66M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • CAVA CAVA GROUP INC · $980.40M
  • LXRX LEXICON PHARMACEUTICALS INC · $128.13M
  • ONC BEONE MEDICINES LTD · $72.66M
  • RVMD REVOLUTION MEDICINES INC · $70.02M
  • SRRK SCHOLAR ROCK HLDG CORP · $64.32M
  • APLS APELLIS PHARMACEUTICALS INC · $63.32M
  • MORF MORPHIC HLDG INC · $48.99M
  • CYTK CYTOKINETICS INC · $44.74M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Artal Group S.A. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-06-15 Sell CAVA GROUP, INC. 3,000,000 $90.30 SEC filing
2026-04-30 Opt exercise LEXICON PHARMACEUTICALS, INC. 20,421,735 — SEC filing

All insider transactions →

Fund Profile

Artal Group S.A. is an SEC-registered 13F filer. As of Q2 2026 it reported 2 US equity positions with a combined value of $931.12M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 2 positions · $931.12M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: CAVA (CAVA GROUP INC) at 54.9%
  • Average position size: $465.56M

Sector Tilt

  • Consumer Discretionary 54.9%
  • Health Care 45.1%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 added, 1 reduced

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 32.4%
Technology 0.8%
Financials 0.2%
Materials 0.0%
Other 20.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 32.01M $980.40M 44.72%
44.72%
New
2 117.55M $128.13M 5.84%
5.84%
New
3 403.93K $72.66M 3.31%
3.31%
New
4 2.53M $70.02M 3.19%
3.19%
New
5 9.06M $64.32M 2.93%
2.93%
New
6 1.66M $63.32M 2.89%
2.89%
New
7 2.14M $48.99M 2.23%
2.23%
New
8 1.52M $44.74M 2.04%
2.04%
New
9 1.82M $42.00M 1.92%
1.92%
New
10 2.80M $39.55M 1.80%
1.80%
New
11 1.64M $35.78M 1.63%
1.63%
New
12 700.00K $30.49M 1.39%
1.39%
New
13 2.47M $25.11M 1.15%
1.15%
New
14 1.81M $25.09M 1.15%
1.15%
New
15 2.50M $24.55M 1.12%
1.12%
New
16 1.51M $24.00M 1.09%
1.09%
New
17 2.52M $21.06M 0.96%
0.96%
New
18 2.02M $18.41M 0.84%
0.84%
New
19 15.63M $17.66M 0.81%
0.81%
New
20 397.00K $17.45M 0.80%
0.80%
New
21 802.90K $16.56M 0.76%
0.76%
New
22 6.60M $14.18M 0.65%
0.65%
New
23 500.00K $14.13M 0.65%
0.65%
New
24 405.24K $14.07M 0.64%
0.64%
New
25 1.19M $13.66M 0.62%
0.62%
New
26 8.59M $12.88M 0.59%
0.59%
New
27 555.56K $12.33M 0.56%
0.56%
New
28 5.57M $11.80M 0.54%
0.54%
New
29 1.00M $11.68M 0.53%
0.53%
New
30 3.66M $11.57M 0.53%
0.53%
New
31 2.00M $11.50M 0.53%
0.53%
New
32 2.81M $10.67M 0.49%
0.49%
New
33 4.75M $10.50M 0.48%
0.48%
New
34 1.91M $10.29M 0.47%
0.47%
New
35 9.14M $9.69M 0.44%
0.44%
New
36 2.50M $9.60M 0.44%
0.44%
New
37 4.72M $9.30M 0.42%
0.42%
New
38 102.70K $8.93M 0.41%
0.41%
New
39 200.00K $8.85M 0.40%
0.40%
New
40 1.00M $8.75M 0.40%
0.40%
New
41 276.08K $8.73M 0.40%
0.40%
New
42 1.72M $8.60M 0.39%
0.39%
New
43 500.00K $8.55M 0.39%
0.39%
New
44 700.00K $8.46M 0.39%
0.39%
New
45 924.77K $8.14M 0.37%
0.37%
New
46 1.85M $8.01M 0.36%
0.36%
New
47 1.00M $7.77M 0.35%
0.35%
New
48 504.98K $7.75M 0.35%
0.35%
New
49 815.09K $7.30M 0.33%
0.33%
New
50 500.00K $6.13M 0.28%
0.28%
New

FAQ

What did Artal Group S.A. buy in 2023-Q3?

In its 2023-Q3 13F filing, Artal Group S.A. reported 100 equity positions worth $2.19B in aggregate; its largest disclosed positions were CAVA ($980.40M), LXRX ($128.13M), ONC ($72.66M).

How large is Artal Group S.A.'s portfolio?

Artal Group S.A. reported $2.19B of long equity holdings across 100 positions as of 2023-Q3. Top-10 holdings account for 70.9% of reported value.

What is Artal Group S.A.'s investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Consumer Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/artal/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →